Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects
- 26 April 2007
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 14 (13), 1039-1044
- https://doi.org/10.1038/sj.gt.3302956
Abstract
The direct, local, administration of adenovirus carrying human BMP-2 cDNA (Ad.BMP-2) heals critical-sized femoral bone defects in rabbit and rat models. However, the outcome is suboptimal and the technology needs to provide a more reliable and uniform outcome. To this end, we investigated whether the timing of Ad.BMP-2 administration influenced the formation of mineralized tissue within the defect. Critical-sized defects were created in the femora of 28 Sprague–Dawley rats. Animals were injected intralesionally with a single, percutaneous injection of Ad.BMP-2 (4 108 plaque-forming units) either intraoperatively (day 0) or 24 h (day 1), 5 days or 10 days after surgery. The femora were evaluated 8 weeks after surgery by X-ray, microcomputed tomography, dual-energy X-ray absorptiometry and biomechanical testing. The incidence of radiological union was markedly increased when administration of Ad.BMP-2 was delayed until days 5 and 10, at which point 86% of the defects healed. These time points also provided greater bone mineral content within the defect site and improved the average mechanical strength of the healed bone. Thus, delaying the injection of Ad.BMP-2 until 5 or 10 days after surgery enables a greater percentage of critical-sized, segmental defects to achieve radiological union, producing a repair tissue with enhanced mineralization and greater mechanical strength.Keywords
This publication has 24 references indexed in Scilit:
- Direct Percutaneous Gene Delivery to Enhance Healing of Segmental Bone DefectsJournal of Bone and Joint Surgery, 2006
- Gene Therapy for the Treatment of Musculoskeletal DiseasesJournal of the American Academy of Orthopaedic Surgeons, 2005
- Gene Transfer Approaches to Enhancing Bone HealingPublished by Springer Nature ,2005
- Adenoviral‐mediated transfer of human BMP‐6 gene accelerates healing in a rabbit ulnar osteotomy modelJournal of Orthopaedic Research, 2004
- Osteogenesis in rats induced by a novel recombinant helper‐dependent bone morphogenetic protein‐9 (BMP‐9) adenovirusThe Journal of Gene Medicine, 2003
- BMP4-Expressing Muscle-Derived Stem Cells Differentiate into Osteogenic Lineage and Improve Bone Healing in Immunocompetent MiceMolecular Therapy, 2002
- Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2The Journal of Bone and Joint Surgery, 2002
- Effect of Bone Morphogenetic Protein-2-Expressing Muscle-Derived Cells on Healing of Critical-Sized Bone Defects in MiceThe Journal of Bone and Joint Surgery-American Volume, 2001
- Gene Therapy-Directed Osteogenesis: BMP-7-Transduced Human Fibroblasts Form Bonein VivoHuman Gene Therapy, 2000
- The Effect of Regional Gene Therapy with Bone Morphogenetic Protein-2-Producing Bone-Marrow Cells on the Repair of Segmental Femoral Defects in Rats*Journal of Bone and Joint Surgery, 1999